BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 1430009)

  • 1. Determination of three metabolites of a new angiotensin-converting enzyme inhibitor, imidapril, in plasma and urine by gas chromatography-mass spectrometry using multiple ion detection.
    Matsuoka M; Horimoto S; Mabuchi M; Banno K
    J Chromatogr; 1992 Oct; 581(1):65-73. PubMed ID: 1430009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly sensitive determination of imidapril, a new angiotensin I-converting enzyme inhibitor, and its active metabolite in human plasma and urine using high-performance liquid chromatography with fluorescent labelling reagent.
    Tagawa K; Hayashi K; Mizobe M; Noda K
    J Chromatogr; 1993 Jul; 617(1):95-103. PubMed ID: 8376543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid determination of a new angiotensin-converting enzyme inhibitor, imidapril, and its active metabolite in human plasma by negative-ion desorption chemical ionization-tandem mass spectrometry (MS/MS).
    Horimoto S; Mabuchi M; Banno K; Sato T
    Chem Pharm Bull (Tokyo); 1993 Apr; 41(4):699-702. PubMed ID: 8508471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 5th communication: isolation and identification of metabolites of imidapril in rats, dogs, and monkeys.
    Yamada Y; Ohashi R; Sugawara Y; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):490-8. PubMed ID: 1642672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay for imidapril, a new angiotensin-converting enzyme inhibitor, and imidaprilat, its active metabolite, in human plasma and urine.
    Yamanaka K; Morikawa S; Murata K; Banno K; Sato T; Takai T; Suzuki T; Mizobe M; Ito M; Ishibashi K
    J Pharm Biomed Anal; 1996 Jan; 14(3):281-7. PubMed ID: 8851752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of a new angiotensin-converting enzyme inhibitor (CS-622) and its active metabolite in plasma and urine by gas chromatography-mass spectrometry using negative ion chemical ionization.
    Shioya H; Shimojo M; Kawahara Y
    J Chromatogr; 1989 Nov; 496(1):129-35. PubMed ID: 2592507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trace analysis of quinapril and its active metabolite, quinaprilat, in human plasma and urine by gas chromatography-negative-ion chemical ionization mass spectrometry.
    Goto N; Kamata T; Ikegami K
    J Chromatogr; 1992 Jul; 578(2):195-201. PubMed ID: 1400797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of a new angiotensin converting enzyme inhibitor and its active metabolite in plasma and urine by gas chromatography-mass spectrometry.
    Kaiser G; Ackermann R; Dieterle W; Dubois JP
    J Chromatogr; 1987 Aug; 419():123-33. PubMed ID: 3667772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of dioxopiperazine metabolites of quinapril in biological fluids by gas chromatography-mass spectrometry.
    Goto N; Sato T; Shigetoshi M; Ikegami K
    J Chromatogr; 1992 Jul; 578(2):203-6. PubMed ID: 1400798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of imidapril and imidaprilat in human plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Mabuchi M; Kano Y; Fukuyama T; Kondo T
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):145-53. PubMed ID: 10574200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of moexipril and moexiprilat, its active metabolite, in human plasma by gas chromatography-negative-ion chemical ionization mass spectrometry.
    Hammes W; Hammes B; Büchsler U; Paar F; Bökens H
    J Chromatogr B Biomed Appl; 1995 Aug; 670(1):81-9. PubMed ID: 7493088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS determination and bioavailability study of imidapril hydrochloride after the oral administration of imidapril tablets in human volunteers.
    Yun JH; Myung JH; Kim HJ; Lee S; Park JS; Kim W; Lee EH; Moon CJ; Hwang SJ
    Arch Pharm Res; 2005 Apr; 28(4):463-8. PubMed ID: 15918521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 7th communication: in vitro metabolism.
    Yamada Y; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):507-12. PubMed ID: 1642674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference from a glucuronide metabolite in the determination of ramipril and ramiprilat in human plasma and urine by gas chromatography-mass spectrometry.
    Persson BA; Fakt C; Ervik M; Ahnoff M
    J Pharm Biomed Anal; 2006 Feb; 40(3):794-8. PubMed ID: 16242284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of benazepril, a new angiotensin-converting enzyme inhibitor, and its active metabolite, benazeprilat, in plasma and urine by capillary gas chromatography-mass-selective detection.
    Sioufi A; Pommier F; Kaiser G; Dubois JP
    J Chromatogr; 1988 Dec; 434(1):239-46. PubMed ID: 3243821
    [No Abstract]   [Full Text] [Related]  

  • 16. An improved method for the measurement of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry.
    Leis HJ; Fauler G; Raspotnig G; Windischhofer W
    Rapid Commun Mass Spectrom; 1999; 13(8):650-3. PubMed ID: 10343410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for the detection of angiotensin-converting enzyme inhibitors, their metabolites, and AT II receptor antagonists.
    Maurer HH; Kraemer T; Arlt JW
    Ther Drug Monit; 1998 Dec; 20(6):706-13. PubMed ID: 9853992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry.
    Leis HJ; Fauler G; Raspotnig G; Windischhofer W
    Rapid Commun Mass Spectrom; 1998; 12(21):1591-4. PubMed ID: 9807834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats.
    Yamanaka K; Takehara N; Murata K; Banno K; Sato T
    J Pharm Sci; 1996 Nov; 85(11):1234-7. PubMed ID: 8923331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay for N tau-methylimidazoleacetic acid, a major metabolite of histamine, in urine and plasma using capillary column gas chromatography-negative ion mass spectrometry.
    Murray S; O'Malley G; Taylor IK; Mallet AI; Taylor GW
    J Chromatogr; 1989 Jun; 491(1):15-25. PubMed ID: 2793969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.